Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomised, Placebo Controlled, Double Blind Monocenter Trial for the Prophylactic Treatment of Diarrhoea With Rifaximin for Travellers to South- and Southeast-Asia

NCT00979056 is registered in ClinicalTrials.gov with Dr. Philipp Zanger, MD MSc DTM as lead sponsor.

NCT NCT00979056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00979056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomised, Placebo Controlled, Double Blind Monocenter Trial for the Prophylactic Treatment of Diarrhoea With Rifaximin for Travellers to South- and Southeast-Asia
Lead sponsor
Dr. Philipp Zanger, MD MSc DTM
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2012
Enrollment
258 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhoea